<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Cell Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Cell. Sci</journal-id>
<journal-id journal-id-type="publisher-id">JCS</journal-id>
<journal-id journal-id-type="hwp">joces</journal-id>
<journal-title-group>
<journal-title>Journal of Cell Science</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9533</issn>
<issn pub-type="epub">1477-9137</issn>
<publisher>
<publisher-name>The Company of Biologists Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28775154</article-id>
<article-id pub-id-type="pmc">5665439</article-id>
<article-id pub-id-type="doi">10.1242/jcs.206425</article-id>
<article-id pub-id-type="publisher-id">JCS206425</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A genome-wide CRISPR screen reconciles the role of N-linked glycosylation in galectin-3 transport to the cell surface</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Stewart</surname>
<given-names>Sarah E.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="author-notes" rid="AN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Menzies</surname>
<given-names>Sam A.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="author-notes" rid="AN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Popa</surname>
<given-names>Stephanie J.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Savinykh</surname>
<given-names>Natalia</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Petrunkina Harrison</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lehner</surname>
<given-names>Paul J.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-3688-3998</contrib-id>
<name>
<surname>Moreau</surname>
<given-names>Kevin</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="corresp" rid="cor1">‡</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge</institution>, <addr-line>Cambridge CB2 0QQ</addr-line>, <country>UK</country></aff>
<aff id="af2"><label>2</label><addr-line>Department of Medicine</addr-line>, <institution>Cambridge Institute for Medical Research</institution>, <addr-line>Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY</addr-line>, <country>UK</country></aff>
<aff id="af3"><label>3</label><institution>NIHR Cambridge BRC Cell Phenotyping Hub</institution>, <addr-line>Department of Medicine</addr-line>, <institution>University of Cambridge</institution>, <addr-line>Cambridge CB2 0QQ</addr-line>, <country>UK</country></aff>
<author-notes>
<fn fn-type="equal" id="AN1">
<label>*</label>
<p>These authors contributed equally to this work</p>
</fn>
<corresp id="cor1"><label>‡</label>Author for correspondence (<email>km510@cam.ac.uk</email>)</corresp>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare no competing or financial interests.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>4</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>130</volume>
<issue>19</issue>
<fpage>3234</fpage>
<lpage>3247</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017. Published by The Company of Biologists Ltd</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="subscription">
<ali:license_ref specific-use="vor" start_date="2018-04-01" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://www.biologists.com/user-licence-1-1/</ali:license_ref>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="joces-130-206425.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Galectins are a family of lectin binding proteins expressed both intracellularly and extracellularly. Galectin-3 (Gal-3, also known as LGALS3) is expressed at the cell surface; however, Gal-3 lacks a signal sequence, and the mechanism of Gal-3 transport to the cell surface remains poorly understood. Here, using a genome-wide CRISPR/Cas9 forward genetic screen for regulators of Gal-3 cell surface localization, we identified genes encoding glycoproteins, enzymes involved in N-linked glycosylation, regulators of ER-Golgi trafficking and proteins involved in immunity. The results of this screening approach led us to address the controversial role of N-linked glycosylation in the transport of Gal-3 to the cell surface. We find that N-linked glycoprotein maturation is not required for Gal-3 transport from the cytosol to the extracellular space, but is important for cell surface binding. Additionally, secreted Gal-3 is predominantly free and not packaged into extracellular vesicles. These data support a secretion pathway independent of N-linked glycoproteins and extracellular vesicles.</p>
</abstract>
<abstract abstract-type="precis">
<p><bold>Summary:</bold> A CRISPR screen identified genes that regulate the cell surface localization of galectins, and data support a secretion pathway for galectin-3 that is independent of N-linked glycoproteins and extracellular vesicles.</p>
</abstract>
<kwd-group>
<title>KEY WORDS</title>
<kwd>Galectin</kwd>
<kwd>Glycosylation</kwd>
<kwd>Unconventional secretion</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Wellcome Trust</institution>
<institution-id>http://dx.doi.org/10.13039/100004440</institution-id>
</institution-wrap>
</funding-source>
<award-id>100574/Z/12/Z</award-id>
<award-id>101835/Z/13/Z</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Medical Research Council</institution>
<institution-id>http://dx.doi.org/10.13039/501100007155</institution-id>
</institution-wrap>
</funding-source>
<award-id>MRC_MC_UU_12012/5</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Institute for Health Research</institution>
<institution-id>http://dx.doi.org/10.13039/501100000272</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>